Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Making LDL Matter Again: Addressing Clinical, Patient, and Payer Barriers in ASCVD Management : Episode 15
Economic Burden and Systemwide Strategies
Panelists discuss how the economic toll of poor LDL-C control demands workplace and systemwide prevention strategies.
EP: 1.Understanding the Current State of LDL-C Goal Attainment and Barriers to Adequate Control in Hyperlipidemia
EP: 2.Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap
EP: 3.Pharmacy-Driven Challenges
EP: 4.Real-World Insights and PROMPT-LIPID
EP: 5.Social Determinants of Health
EP: 6.The 2013 Guideline Shift
EP: 7.Unintended Consequences of Metric Changes
EP: 8.Reinstating LDL-C Targets
EP: 9.International LDL Thresholds
EP: 10.Nonstatin Therapy Decisions
EP: 11.PCSK9 Inhibitor Underuse
EP: 12.Payer and Prior Authorization Barriers
EP: 13.Adherence and Persistence
EP: 14.Cumulative LDL-C Exposure
Now Viewing
EP: 15.Economic Burden and Systemwide Strategies
Panelists discuss how poor low-density lipoprotein cholesterol (LDL-C) control imposes substantial economic costs through hospitalizations, lost productivity, and long-term treatment of cardiovascular events.
They highlight that preventive strategies—such as workplace screenings and wellness incentives—can improve early detection and reduce downstream costs.
Panelists conclude that systemwide coordination between employers, payers, and clinicians is necessary to make cholesterol control a sustainable public health priority.
Related Videos
Related Content
